Skip to content

DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study

DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06095518
Acronym
DIC-ECMO
Enrollment
49
Registered
2023-10-23
Start date
2023-05-30
Completion date
2025-12-31
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Circulation; Complications, Extracorporeal Membrane Oxygenation Complication

Keywords

ECMO, Thrombosis, Haemorrhage

Brief summary

To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.

Interventions

DIAGNOSTIC_TESTDIC markers and Thrombin Generation Parameters

Observation of DIC markers and thrombin generation parameters in patients with and without thrombotic and hemorrhagic complications

Sponsors

Queen Mary Hospital, Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age ≧ 18; AND * Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital or Tuen Mun Hospital in Hong Kong; AND * Require either veno-arterial (VA) or veno-venous (VV) extracorporeal membrane oxygenation (ECMO) support.

Exclusion criteria

* Patients who are on central VA-ECMO support; OR * Patients with missing clinical data; OR * Patients with pre-existing thromboembolism requiring long term anticoagulation prior to ECMO cannulation; OR * Post-operative admissions

Design outcomes

Primary

MeasureTime frameDescription
Composite of thrombotic and hemorrhagic eventsFrom the start of ECMO support to the end of ECMO support (which can be variable, typically around 5 days to 1 week)Thrombotic events include circuit-related thrombosis (e.g. oxygenator failure requiring circuit change) OR Non-circuit-related thrombosis (e.g. new pulmonary embolism or deep vein thrombosis while on ECMO. Hemorrhagic events include bleeding at critical sites or requiring interventions.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026